ologists around the world because of exene should really be considered according to them safe only when phase 3 trials are completed and it's also unclear whether soldiers for example would have a way to stick to to make a decision themselves or whether they could because to do that so there has been criticism but it shows of course also that that the chinese leadership thinks that it is. on the way to having a big scene again many questions will remain. but the country clearly wants to be the 1st country to shoot to bring a vaccine to the domestic onto the international markets and they're pushing for this hard to speak with us a little bit perhaps more broadly speaking about the concern in china over the cove in 1000 numbers going up again. so what china has done so far is that it really seems to have brought their domestic transmissions under control we have almost no news about domestic transmissions anymore we have just completed an 8 day holiday public holiday with 5 to 600 millions people have been travelling most of the people you can you cannot really see them because it's dark

equity inclusion in medical ethics health and public health and vaccination far more broadly than 1000 exene is on the beginning of a longer project of anti-racist work in medicine so this potentially could be an uncomfortable conversation about race medicine. vaccine trials and the ready for a jump into the comments i want to be part of today. hi larry linda hello granted we could miss you going to be town team integrate this today they have so much knowledge you're about to see blood on you linda reintroduce your south stream audience. hello femi thank you for having me i'm going to go about president and c.e.o. of the black women's health imperative the only national organization focused on black women's health emotional physical health and mental health so happy to be here welcome back hello there glenn tell everybody who you are like i can me look melinda good to see you bald i am arkell and allison based in philadelphia i'm a currently a visiting scholar at the national bioethics center and at tuskegee university and i'm also a fellow at harvard medical school and both research bioethi

something that has been criticized by epidemiology and immuno all knowledge is around the world because of exeneshould really be considered according to them safe only when phase 3 trials are completed and it's also unclear whether soldiers for example would have a way to stick to to make a decision themselves or whether they could because to do that so there has been criticism but it shows of course also that that the chinese leadership thinks that it is on the way to having a big scene again many questions will remain. but the country clearly wants to be the 1st country to to bring a vaccine to the domestic and to the international market and they're pushing for this hard to speak with us a little bit perhaps more broadly speaking about the concern in china over the cove in 1000 numbers going up again. so what china has done so far is that it really seems to have brought the domestic transmissions under control we have almost no news about domestic transmissions anymore we have just completed an 8 day holiday public holiday where 5 to 600 millions people have been travelling most of the people

that axion is kicking in they may get infected so that's what we're checking for is to make sure that exene doesn't it in an early start causing tissue now again we're not confirm that that's a problem yet it may be just fine but that's certainly something scientists are thinking i mean you know last time you were on we talked a little bit about how big multinational pharmaceutical companies seem to be benefiting from research money has that improved since i must put to you. not yet but i'm going to be that we have anybody carries on these big companies they have obviously spent billions of dollars in many decades paving the way for technologies that i now use but it would help i think for there to be more chips on the table on more technology so my company in particular are anybody is different than the other . chose to turn off are the anybody that causes activation of the union system and this was a safety feature we were concerned that you could potentially el patient even anybody to block the virus and at the same time it made us information that could be problematic i think what compa

>> we can't speculate on exen exactly we're going to get it, before or after the election. it is important but it is not everything just like the elections are important but not everything. if you look at the data, you continue to see improvements in the coming data in the u.s. are onomic -- the data better than what economists are expecting. interestingly as i mentioned this, manufacturing and you're starting to see improvement on the consumer side as well. during the lockdown over the last number of months, consumers, they now seem to be starting to spend them. automotive sales are up quite a bit and also the o.r. area of improvement we're seeing in the housing market probably relates to the low interest rate environment. two areas i think are doing quite well. obviously a boost from the fiscal side would help. the improvement in the labor arket that we're seeing. service companies and manufacturing companies want to hire more. all of that is important for the consumer. i think there is some tail wind there. ann marie: the p.m.i.'s we're set to get on friday are going to

that could well happen so so we all think that probably the 1st 2 exene is we'll look at around to the same time and that and you and additional back scenes will come out of the idea that intent is that by the end of 2021 we would have had $2000000000.00 doses of vaccine that would be. distributed to countries around the world use a fairly distributed but how can we sure ensure that fair and rule distribution. so this is a concern i think that justified concern and to address this concern. dubay show to get that with various other stakeholders and the gavi it's actually has a separatist platform or a mechanism which they call kovacs so kovacs is meant to have a pooled risk sharing priest financing mechanism but also negotiating prices. and and then basically supporting a whole range of that seems but it also ensuring so do have mechanisms or it could be like a legal mechanisms that every country will have the equal distribution so the thought the and the intent is here indeed that in the initial plant when we have still limited supply that would be the 3 percent of course will to the p